The global endoscopic spinal surgery market was valued at $536.9 million in 2021, and is projected to reach $1,096.31 million by 2031, registering a CAGR of 7.4% from 2022 to 2031.
Endoscopic spinal surgery (ESS) is referred to surgical procedure, which utilizes a micro-sized incisions which is less than 1-inch and a small tubular system together with an endoscope to get clear image of the internal organs of the human body. This type of spinal surgeries has now become a choice of treatment for many patients owing to the advances in optics, high quality visualization of tissues, and efficient spinal imaging that is offered by ESS. In addition, this procedure is one of the minimally invasive surgeries that provide patients fastest recovery after the surgery. Furthermore, the surgery involves use of tubular retractors and endoscope, which allows indirect visualization of the internal organs. In addition, indirect visualization during procedures has been replaced the traditional forms of direct visualization across many different surgical specialties, which further increases demand for endoscopic spinal surgery.
According to the World Health Organization (WHO), in 2030, it is anticipated there will be about 1 billion older people worldwide, which is equivalent to 12% of the total population. The share of geriatric population is anticipated to continue to grow in the following 20 years. By 2050, it is estimated that there will be 1.6 billion older people worldwide, representing 16.7% of the total world population of 9.4 billion. In addition, according to several studies, it is reported that geriatric population is more prone to several age-related chronic illnesses such as lower back pain and spinal arthritis that may require special treatment procedures.
This anticipated rise in the number of aged population propel demand for endoscopic spinal surgeries as the treatment option as it is less painful and offers faster recovery, which further leads to expansion of the market during the forecast period.
In addition, there is a rise in cases of the spinal disorders such as ankylosing spondylitis, spinal stenosis, herniated discs, hematoma, degenerative disc disease, vertebral fractures and others. According to the Johns Hopkins Arthritis Center, in the recent population estimates indicate that the prevalence of ankylosing spondylitis (AS) in the U. S. is approximately 0.2-0.5% and based on data from multiple countries, the age- and sex-adjusted incidence of ankylosing spondylitis (AS) is 0.4-14 per 100,000 people. In addition, in a year about 2% of people get a herniated disk. Thus, there is a huge prevalence of spinal disorders around the globe, which also increases demand for endoscopic spinal surgery, thereby boosting adoption of instruments associated with the surgery. This further propels growth of the endoscopic spinal surgery market.
Furthermore, technological advancements in this field have led to increase in adoption of this technique among the healthcare providers and also by the patients. Complexity of spinal surgery causes serious obstacles during the procedure, and can lead to less effective surgery, therefore, to overcome this, huge technological advances have been made by researchers. Moreover, use of 3D endoscopes have reduced the risk of damage and enhanced accuracy of the procedure. For instance, introduction of a highly precise procedure for endoscopic spinal surgery with the combination of four key technologies including 3D analysis, advanced algorithms, patient connection platform, and cross modality image registration developed by Mazor Robotics. In addition, governments and other organizations provide fundings to initiate research and development activities in certain regions to bring development in healthcare facilities. This also accelerates growth of the market.
In addition, factors such as rise in adoption of minimally invasive spinal surgeries, increase in prevalence of spinal disorders, and increase in geriatric population around the globe propel growth of the market. Although there are many factors driving growth of the market, high cost associated with endoscopic spine surgery and lack of adequate reimbursement policies in emerging regions hampers growth of the market.
The endoscopic spinal surgery market is studied on the basis of product type, procedure type, end user, and region. By product type, the market is segmented into endoscopes and endoscopic devices. By procedure type, transforaminal endoscopic procedures, interlaminar endoscopic procedures, endoscopic posterior foraminotomy & cervical discectomy and endoscopic visualized rhizotomy. By end user, it is classified into hospitals & clinics and ambulatory surgical centers. Region wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include Endovision Co. Ltd, Globus Medical Inc., Jiomax Inc., Johnson & Johnson (Depuy Synthes Spine, Inc. ), Karl Storz Se & Co. Kg, Medtronic Plc., Medicaltek Co., Ltd., Olympus Corporation, Richard Wolf, Stryker Corporation, and Zimmer Biomet Holdings, Inc.
Endoscopic spinal surgery (ESS) is referred to surgical procedure, which utilizes a micro-sized incisions which is less than 1-inch and a small tubular system together with an endoscope to get clear image of the internal organs of the human body. This type of spinal surgeries has now become a choice of treatment for many patients owing to the advances in optics, high quality visualization of tissues, and efficient spinal imaging that is offered by ESS. In addition, this procedure is one of the minimally invasive surgeries that provide patients fastest recovery after the surgery. Furthermore, the surgery involves use of tubular retractors and endoscope, which allows indirect visualization of the internal organs. In addition, indirect visualization during procedures has been replaced the traditional forms of direct visualization across many different surgical specialties, which further increases demand for endoscopic spinal surgery.
According to the World Health Organization (WHO), in 2030, it is anticipated there will be about 1 billion older people worldwide, which is equivalent to 12% of the total population. The share of geriatric population is anticipated to continue to grow in the following 20 years. By 2050, it is estimated that there will be 1.6 billion older people worldwide, representing 16.7% of the total world population of 9.4 billion. In addition, according to several studies, it is reported that geriatric population is more prone to several age-related chronic illnesses such as lower back pain and spinal arthritis that may require special treatment procedures.
This anticipated rise in the number of aged population propel demand for endoscopic spinal surgeries as the treatment option as it is less painful and offers faster recovery, which further leads to expansion of the market during the forecast period.
In addition, there is a rise in cases of the spinal disorders such as ankylosing spondylitis, spinal stenosis, herniated discs, hematoma, degenerative disc disease, vertebral fractures and others. According to the Johns Hopkins Arthritis Center, in the recent population estimates indicate that the prevalence of ankylosing spondylitis (AS) in the U. S. is approximately 0.2-0.5% and based on data from multiple countries, the age- and sex-adjusted incidence of ankylosing spondylitis (AS) is 0.4-14 per 100,000 people. In addition, in a year about 2% of people get a herniated disk. Thus, there is a huge prevalence of spinal disorders around the globe, which also increases demand for endoscopic spinal surgery, thereby boosting adoption of instruments associated with the surgery. This further propels growth of the endoscopic spinal surgery market.
Furthermore, technological advancements in this field have led to increase in adoption of this technique among the healthcare providers and also by the patients. Complexity of spinal surgery causes serious obstacles during the procedure, and can lead to less effective surgery, therefore, to overcome this, huge technological advances have been made by researchers. Moreover, use of 3D endoscopes have reduced the risk of damage and enhanced accuracy of the procedure. For instance, introduction of a highly precise procedure for endoscopic spinal surgery with the combination of four key technologies including 3D analysis, advanced algorithms, patient connection platform, and cross modality image registration developed by Mazor Robotics. In addition, governments and other organizations provide fundings to initiate research and development activities in certain regions to bring development in healthcare facilities. This also accelerates growth of the market.
In addition, factors such as rise in adoption of minimally invasive spinal surgeries, increase in prevalence of spinal disorders, and increase in geriatric population around the globe propel growth of the market. Although there are many factors driving growth of the market, high cost associated with endoscopic spine surgery and lack of adequate reimbursement policies in emerging regions hampers growth of the market.
The endoscopic spinal surgery market is studied on the basis of product type, procedure type, end user, and region. By product type, the market is segmented into endoscopes and endoscopic devices. By procedure type, transforaminal endoscopic procedures, interlaminar endoscopic procedures, endoscopic posterior foraminotomy & cervical discectomy and endoscopic visualized rhizotomy. By end user, it is classified into hospitals & clinics and ambulatory surgical centers. Region wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include Endovision Co. Ltd, Globus Medical Inc., Jiomax Inc., Johnson & Johnson (Depuy Synthes Spine, Inc. ), Karl Storz Se & Co. Kg, Medtronic Plc., Medicaltek Co., Ltd., Olympus Corporation, Richard Wolf, Stryker Corporation, and Zimmer Biomet Holdings, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the endoscopic spinal surgery market analysis from 2021 to 2031 to identify the prevailing endoscopic spinal surgery market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the endoscopic spinal surgery market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global endoscopic spinal surgery market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Endoscopes
- Endoscopic Devices
By Procedure type
- Transforaminal Endoscopic Procedures
- Interlaminar Endoscopic Procedures
- Endoscopic Posterior Foraminotomy and Cervical Discectomy
- Endoscopic Visualized Rhizotomy
By End User
- Hospital and Clinics
- Ambulatory Surgical Centers
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
- MEDTRONIC PLC.
- MEDICALTEK CO., LTD.
- STRYKER CORPORATION
- ZIMMER BIOMET HOLDINGS, INC.
- OLYMPUS CORPORATION
- KARL STORZ SE & CO. KG
- Richard Wolf GmbH
- GLOBUS MEDICAL INC.
- Endovision Co., Ltd.
- joimax GmbH
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Endoscopes
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Endoscopic Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Transforaminal Endoscopic Procedures
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Interlaminar Endoscopic Procedures
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Endoscopic Posterior Foraminotomy and Cervical Discectomy
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Endoscopic Visualized Rhizotomy
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
CHAPTER 6: ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
CHAPTER 7: ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Procedure type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Procedure type
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Procedure type
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Procedure type
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Procedure type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Procedure type
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Procedure type
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Procedure type
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Procedure type
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Procedure type
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Procedure type
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Procedure type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Procedure type
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Procedure type
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Procedure type
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Procedure type
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Procedure type
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Procedure type
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Procedure type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Procedure type
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Procedure type
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Procedure type
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Procedure type
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 MEDTRONIC PLC.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 MEDICALTEK CO., LTD.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 STRYKER CORPORATION
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 ZIMMER BIOMET HOLDINGS, INC.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 OLYMPUS CORPORATION
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 KARL STORZ SE & CO. KG
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Richard Wolf GmbH
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 GLOBUS MEDICAL INC.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Endovision Co., Ltd.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 joimax GmbH
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Endoscopic Spinal Surgery Market,' the endoscopic spinal surgery market size was valued at $536.90 million in 2021, and is estimated to reach $1,096.31 million by 2031, growing at a CAGR of 7.4% from 2022 to 2031.Endoscopic spinal surgery is a minimally invasive procedure that makes it easier for surgeons to perform complex surgeries with less efforts and obstacles. This complexity of spinal surgery can provide major challenges for surgeons, such as possibility of implanting a screw in incorrect location, which could result in paralysis or less effective surgery. However, use of endoscope in spine surgery have decreased the possibility of surgical errors and thereby improved surgical precision. Furthermore, endoscopic spinal surgery can be used to treat cervical, thoracic, and lumbar spines associated abnormalities, and offers several advantages over other traditional surgeries such as less tissue dissection and muscle trauma, less blood loss, and less disruption of epidural blood supply, which prevents epidural fibrosis and scarring, reduced hospital stay, early functional recovery, improvement in quality of life, and improved clinical results.
One of the major endoscopic spinal surgery market trends is surge in geriatric population across the globe suffering from spinal diseases and a subsequent increase in demand for endoscopes and other related instruments and equipment, which propels growth of the market.
In addition, technological advancements in the field of surgery also drive the endoscopic spinal surgery market growth. For instance, nowadays, to get HD optimization of endoscopic images during spinal endoscopy, light generation and transmission techniques are used. For instance, Xenon light sources with 300 watts or LED and laser light technology are adopted to get full HD image of internal organs of patients.
In addition, development of micro endoscopic spine surgery is also an advance technique, which offers pain-free operation, minimum postoperative pain, and proves to be an easy way to get rid of back pain. In addition, India have proved to be the micro endoscopic spine surgery hub, hence attracting patients from around the globe. Furthermore, this system offers advantage of being combined with paperless electronic health records (EHR), which leads to increase in their demand and propels the market growth.
Moreover, according to the World Health Organization, every year lives of approximately 1.3 million people are cut short as a result of a road traffic crash and between 20 and 50 million more people suffer non-fatal injuries, with many incurring a disability as a result of their injury. Thus, higher incidences of spinal injury cases, owing to accidents propels demand for endoscopic spinal surgery and further propels growth of the market.
The endoscopic spinal surgery market is segmented on the basis of product type, procedure type end user, and region. By product type, the market is segmented into endoscope and endoscopic devices. The endoscopic devices segment dominated the market in 2021, owing to rise in demand for endoscopic spinal surgery around the globe. In addition, new device launches and approvals by key market players contribute toward increase in sales of this segment.
By procedure type, the market is segmented into transforaminal endoscopic procedures, interlaminar endoscopic procedures, endoscopic posterior foraminotomy & cervical discectomy, and endoscopic visualized rhizotomy. The transforaminal endoscopic procedures segment dominated the market in 2021, owing to rise in cases of disc herniation of lumbar and lower thoracic spine and adoption of transforaminal endoscopic procedures for their treatment.
Based on end user, the endoscopic spinal surgery market is categorized into hospitals and clinics and ambulatory surgical centers. The hospitals and clinics segment accounted for the largest share in the market, owing to adoption of well-equipped & advanced surgical devices in hospitals, rising cases of road accidents & emergency hospitalizations, and surge in patient visits to hospitals and clinics in emerging countries post pandemic. However, the ambulatory surgical centers segment is expected to grow with the fastest CAGR during the forecast period.
Region wise, the endoscopic spinal surgery industry is studied across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for major share of the endoscopic spinal surgery market share in 2021, owing to presence of key players, rise in government initiatives, well-developed healthcare infrastructure, and higher prevalence of spinal stenosis and herniated discs. However, Asia-Pacific is expected to witness highest growth rate for the endoscopic spinal surgery market throughout the forecast period, owing to investments by public and private market players in this field, increase in medical tourism, and abundance of raw material in this region.
KEY FINDINGS OF THE STUDY
On the basis of product type, the endoscopic devices segment held the largest market share in 2021, whereas the endoscopes segment is expected to remain dominant during the forecast period.On the basis of procedure type, the transforaminal endoscopic procedures segment held the largest market share in 2021, whereas the interlaminar endoscopic procedures segment is expected to remain dominant during the forecast period.
On the basis of end user, the hospitals and clinics segment held largest market share in 2021, whereas the ambulatory surgical centers segment is expected to grow at the fastest CAGR rate during the forecast period.
Region wise, North America held the largest share of the endoscopic spinal surgery market in the year 2021, whereas the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Depuy Synthes Spine, Inc. (Johnson & Johnson)
- Medtronic PLC.
- Medicaltek Co. Ltd.
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Olympus Corporation
- Karl Storz SE & Co. KG
- Richard Wolf GmbH
- Globus Medical Inc.
- Endovision Co. Ltd.
- Joimax GmbH
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 236 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 536.9 million |
| Forecasted Market Value ( USD | $ 1096.31 million |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
